Article Complete
    AIM

    Healthcare Co Roche to Launch Second India Technology Hub in Hyderabad

    Healthcare Co Roche to Launch Second India Technology Hub in Hyderabad

    The new facility will support digital applications and IT services, with operations set to begin in early 2027.

    Healthcare Co Roche to Launch Second India Technology Hub in Hyderabad
    Sanjana Gupta··Updated OCTOBER 19, 2026, 4:57 PM
    5 min

    Healthcare company Roche will open its second Digital Technology Hub in India in Hyderabad, expanding its global technology network. The new hub will begin operations in the first quarter of 2027 and will scale its workforce and capabilities over the coming years.

    The company said the Hyderabad facility will strengthen its digital and technology operations by adding capacity in life sciences expertise and supporting the development of digital solutions. 

    The hub will join Roche’s existing Pune site as part of its India technology footprint.

    Ramesh Durvasula, Chief Data Officer and Chief AI Officer a.i. at Roche, said Hyderabad offers access to talent in the pharmaceutical and life sciences sectors. “By tapping into India’s vibrant healthcare and technology ecosystem, we are creating scalable data-driven innovations to advance our core purpose of improving patient care,” Durvasula said in a statement.

    The two India-based Digital Technology Hubs will house teams working on IT services and digital applications across areas including biostatistics, enterprise resource planning (ERP), and medical safety. Roche said the Hyderabad site will add domain expertise and support the development of its digital solutions.

    Raja Jamalamadaka, VP and Site Head for Roche Pune and Hyderabad Sites, said the investment reflects the company’s long-term commitment to India. “By scaling our footprint, we are enhancing our capability to orchestrate seamless, next-generation digital and technology solutions,” he added.

    Roche, headquartered in Basel, Switzerland, operates across diagnostics and pharmaceuticals, serving patients in more than 150 countries. The company focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology.

    Your reaction

    Discussion

    What's your take on this story?

    0/1000

    No comments yet — be the first to share your view.

    Explore our newsletters

    Build your routine with some of our top newsletters or view them all here.

    Wake up informed

    Make sense of the day's AI news and breakthroughs with our morning briefing.

    Belamy
    WeeklyBelamySee the latest

    Industry intelligence

    Receive a roundup of AI adoption stories by industry vertical, curated for professionals.

    3x WeeklySector6See the latest

    By signing up, you agree to our Privacy Policy.

    Membership

    Stay ahead with AI insights.

    Unlimited access to premium articles, exclusive analysis, and the stories shaping India's AI economy.

    Subscribe now

    AIM Americas

    1190 Miraloma Way Suite P, Sunnyvale, CA 94085

    AIM India

    1st Floor, Sakti Statesman, Bellandur, Bengaluru – 560103

    © 2026 AIM. All rights reserved.